CN105106909A - Traditional Chinese medicine composition for treating hepatitis A - Google Patents
Traditional Chinese medicine composition for treating hepatitis A Download PDFInfo
- Publication number
- CN105106909A CN105106909A CN201510619411.3A CN201510619411A CN105106909A CN 105106909 A CN105106909 A CN 105106909A CN 201510619411 A CN201510619411 A CN 201510619411A CN 105106909 A CN105106909 A CN 105106909A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- rhizoma
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention discloses a traditional Chinese medicine composition for treating hepatitis A. The traditional Chinese medicine composition comprises, by weight, 10-30 parts of smoked plum, 5-25 parts of rhizoma coptidis, 5-20 parts of cortex phellodendri, 5-25 parts of desmodium, 5-20 parts of monkshood, 5-25 parts of dried ginger, 5-20 parts of cassia twig, 2-8 parts of asarum, 5-25 parts of ginseng, 5-25 parts of angelica sinensis, 10-40 parts of rhizoma alismatis, 5-20 parts of curcuma zedoary, 5-25 parts of radix astragali, 5-20 parts of pericarpium citri reticulatae viride, 5-25 parts of lalang grass rhizome, 5-20 parts of tangerine peel, 5-25 parts of sophora flavescens, 5-25 parts of radix bupleuri, 5-20 parts of polyporus umbellatus, 5-20 parts of felwort, 5-25 parts of oldenlandia diffusa, 5-25 parts of Chinese lobelia and 5-15 parts of liquorice. The traditional Chinese medicine composition has effects of soothing the liver and relieving stagnant qi, regulating qi flowing for strengthening the spleen, clearing away heat and toxic materials and removing dampness and relieving jaundice, and is evident in curative effect on hepatitis A and reliable in effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical product not determining structure of traditional herbal medicines, especially a kind of Chinese medicine composition for the treatment of hepatitis A.
Background technology
Hepatitis A is a kind of viral hepatitis caused by hepatitis A virus (HAV) (HAV), mainly infect through excrement mouth (or anus mouth) route of transmission, caused a disease by the hepatitis A virus (abbreviation hepatitis A virus (HAV)) of transmission, namely by patient incubation period or acute stage feces, hepatitis A virus (HAV) polluted source, food, apparatus and life close contact per os in blood enter gastrointestinal tract and propagate.Hepatitis A virus (HAV) has stronger resistance and can survive in external environment for a long time to various extraneous factor, by various contaminated articles (hands, articles for daily use, medicated clothing, coverlet etc.) and water and food transmission, also can carry through fly and propagate.The clinical manifestation of hepatitis A patient is: weak, the anorexia of generating heat, detest oil, yellow sclera, hepatalgia, liver enlargement, liver function index is abnormal raises, small number of patients also may make that edema or cerebral edema appear in renal function exacerbation, liver function worsens, even dead.At present, the Western medicine for the treatment of hepatitis A is a lot, and general patient uses inosine, vitamin C, liver-protecting tablet etc., though there is certain curative effect, there is the length course for the treatment of, side effect deficiency that is large and that easily recur.
Motherland's medical science is thought, hepatitis A is that exopathogen causes damage owing to experiencing damp and hot, epidemic disease is malicious etc., and transformation and transportation of the spleen and stomach neglect one's duty, causes caused by liver catharsis neglects one's duty.
According to theory of Chinese medical science, for the pathogeny of hepatitis A, adopt the method for the treatment of of soothing the liver dispelling the stagnated QI, heat-clearing and toxic substances removing, carry out dialectical composition of prescription, to reach the object for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
Treat hepatitis A have that the course for the treatment of is long, side effect large and the deficiency of easily recurrence to overcome in prior art, the invention provides a kind of prepare easy, cost is low, evident in efficacy, the Chinese medicine composition for the treatment of hepatitis A that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: a kind of Chinese medicine composition for the treatment of hepatitis A, it is characterized in that: its raw material of Chinese medicine and weight are: Fructus Mume 10-30 part, Rhizoma Coptidis 5-25 part, Cortex Phellodendri 5-20 part, Herba Lysimachiae 5-25 part, Radix Aconiti Lateralis Preparata 5-20 part, Rhizoma Zingiberis 5-25 part, Ramulus Cinnamomi 5-20 part, Herba Asari 2-8 part, Radix Ginseng 5-25 part, Radix Angelicae Sinensis 5-25 part, Rhizoma Alismatis 10-40 part, Rhizoma Curcumae 5-20 part, Radix Astragali 5-25 part, Pericarpium Citri Reticulatae Viride 5-20 part, Rhizoma Imperatae 5-25 part, Pericarpium Citri Reticulatae 5-20 part, Radix Sophorae Flavescentis 5-25 part, Radix Bupleuri 5-25 part, Polyporus 5-20 part, Radix Gentianae 5-20 part, Herba Hedyotidis Diffusae 5-25 part, Herba Lobeliae Chinensis 5-25 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: a kind of Chinese medicine composition for the treatment of hepatitis A, is characterized in that: its raw material of Chinese medicine and weight are: Fructus Mume 20 parts, Rhizoma Coptidis 15 parts, Cortex Phellodendri 10 parts, Herba Lysimachiae 15 parts, Radix Aconiti Lateralis Preparata 10 parts, Rhizoma Zingiberis 15 parts, Ramulus Cinnamomi 12 parts, Herba Asari 5 parts, Radix Ginseng 15 parts, Radix Angelicae Sinensis 15 parts, Rhizoma Alismatis 30 parts, Rhizoma Curcumae 10 parts, the Radix Astragali 15 parts, 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Imperatae 15 parts, Pericarpium Citri Reticulatae 10 parts, Radix Sophorae Flavescentis 15 parts, Radix Bupleuri 15 parts, Polyporus 10 parts, Radix Gentianae 10 parts, Herba Hedyotidis Diffusae 15 parts, Herba Lobeliae Chinensis 15 parts, 10 parts, Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription.In Chinese medicine composition of the present invention: Fructus Mume has effect of warming middle-JIAO of astringing the lung, relieving diarrhea with astringents, promoting the production of body fluid to quench thirst; Rhizoma Coptidis has effect of heat clearing and damp drying, eliminating fire and detoxication; Effect that Cortex Phellodendri has heat clearing and damp drying, pathogenic fire purging removes steaming, detoxification sore treatment; Herba Lysimachiae has effect of heat-clearing and toxic substances removing, dissipating blood stasis for subsidence of swelling, dampness removing jaundice eliminating; Radix Aconiti Lateralis Preparata has recuperating depleted YANG and rescuing the patient from collapse, mends effect that is fiery supporing yang, dispersing cold for relieving pain; Rhizoma Zingiberis has warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, effect of warming the lung to resolve fluid-retention; Ramulus Cinnamomi has effect of diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, dispersing cold for relieving pain; Herba Asari has expelling wind and cold
,understand things pain-stopping
,effect of warming the lung to resolve fluid-retention; Radix Ginseng has strongly invigorating primordial QI, multiple arteries and veins takes off admittedly, effect of invigorating the spleen to benefit the lung; Radix Angelicae Sinensis have enrich blood invigorate blood circulation, effect of menstruction regulating and pain relieving, loosening bowel to relieve constipation; Rhizoma Alismatis has promoting diuresis to eliminate damp pathogen, expel the heat-evil treating stranguria effect; Rhizoma Curcumae has effect of circulation of qi promoting removing blood stasis, removing food stagnancy pain relieving; The Radix Astragali has effect that benefiting QI for strengthening the superficies, arresting sweating are admittedly de-, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema; Pericarpium Citri Reticulatae Viride has the stagnant effect of soothing the liver dispelling the stagnated QI, removing food stagnancyization; Rhizoma Imperatae has effect of cooling blood for hemostasis, clearing away heat and promoting diuresis; Pericarpium Citri Reticulatae has effect of diuretic, drying dampness to eliminate phlegm in regulating qi-flowing for strengthening spleen, tune; Radix Sophorae Flavescentis has effect of heat clearing and damp drying, wind dispelling insecticide; Radix Bupleuri have evacuate bring down a fever, effect of yang invigorating soothing liver-QI; Polyporus has effect of promoting diuresis to eliminate damp pathogen; Radix Gentianae has effect of heat clearing and damp drying, eliminating pathogen in the liver gallbladder fire; Herba Hedyotidis Diffusae has effect of heat-clearing and toxic substances removing, inducing diuresis to remove edema, promoting blood circulation and stopping pain; Herba Lobeliae Chinensis has effect of inducing diuresis to remove edema, heat-clearing and toxic substances removing; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription.The selected medicament composing prescription of the present invention, its drug component is through dialectical compatibility, and help using mutually assistant, long memorial liver dispelling the stagnated QI, regulating qi-flowing for strengthening spleen, heat-clearing and toxic substances removing, dampness removing jaundice eliminating effect, reach treating both the principal and secondary aspects of a disease to the treatment of hepatitis A altogether.
The component of the present composition all adopts natural raw material of Chinese medicine, and its preparation is easy, medicine source is wide, cost is low.The present invention follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopts the use that is decocted in water for oral dose.Through clinical practice checking, it is reliably evident in efficacy, mild in medicine property and, do not occur toxic and side effects, effective percentage reaches 93%, cure rate 71%.
Detailed description of the invention
Below in conjunction with embodiment, the invention will be further described.
embodiment 1
Treat a Chinese medicine composition for hepatitis A, its raw material of Chinese medicine and weight proportion are: Fructus Mume 20g, Rhizoma Coptidis 15g, Cortex Phellodendri 10g, Herba Lysimachiae 15g, Radix Aconiti Lateralis Preparata 10g, Rhizoma Zingiberis 15g, Ramulus Cinnamomi 12g, Herba Asari 5g, Radix Ginseng 15g, Radix Angelicae Sinensis 15g, Rhizoma Alismatis 30g, Rhizoma Curcumae 10g, Radix Astragali 15g, Pericarpium Citri Reticulatae Viride 10g, Rhizoma Imperatae 15g, Pericarpium Citri Reticulatae 10g, Radix Sophorae Flavescentis 15g, Radix Bupleuri 15g, Polyporus 10g, Radix Gentianae 10g, Herba Hedyotidis Diffusae 15g, Herba Lobeliae Chinensis 15g, Radix Glycyrrhizae 10g.
embodiment 2
Treat a Chinese medicine composition for hepatitis A, its raw material of Chinese medicine and weight proportion are: Fructus Mume 15g, Rhizoma Coptidis 25g, Cortex Phellodendri 5g, Herba Lysimachiae 20g, Radix Aconiti Lateralis Preparata 12g, Rhizoma Zingiberis 25g, Ramulus Cinnamomi 10g, Herba Asari 6g, Radix Ginseng 5g, Radix Angelicae Sinensis 25g, Rhizoma Alismatis 15g, Rhizoma Curcumae 20g, Radix Astragali 10g, Pericarpium Citri Reticulatae Viride 15g, Rhizoma Imperatae 5g, Pericarpium Citri Reticulatae 20g, Radix Sophorae Flavescentis 10g, Radix Bupleuri 25g, Polyporus 12g, Radix Gentianae 20g, Herba Hedyotidis Diffusae 5g, Herba Lobeliae Chinensis 25g, Radix Glycyrrhizae 12g.
embodiment 3
Treat a Chinese medicine composition for hepatitis A, its raw material of Chinese medicine and weight proportion are: Fructus Mume 25g, Rhizoma Coptidis 5g, Cortex Phellodendri 20g, Herba Lysimachiae 10g, Radix Aconiti Lateralis Preparata 15g, Rhizoma Zingiberis 5g, Ramulus Cinnamomi 20g, Herba Asari 4g, Radix Ginseng 10g, Radix Angelicae Sinensis 20g, Rhizoma Alismatis 10g, Rhizoma Curcumae 15g, Radix Astragali 25g, Pericarpium Citri Reticulatae Viride 5g, Rhizoma Imperatae 20g, Pericarpium Citri Reticulatae 12g, Radix Sophorae Flavescentis 25g, Radix Bupleuri 5g, Polyporus 20g, Radix Gentianae 12g, Herba Hedyotidis Diffusae 25g, Herba Lobeliae Chinensis 5g, Radix Glycyrrhizae 8g.
embodiment 4
Treat a Chinese medicine composition for hepatitis A, its raw material of Chinese medicine and weight proportion are: Fructus Mume 10g, Rhizoma Coptidis 20g, Cortex Phellodendri 5g, Herba Lysimachiae 25g, Radix Aconiti Lateralis Preparata 5g, Rhizoma Zingiberis 20g, Ramulus Cinnamomi 5g, Herba Asari 8g, Radix Ginseng 20g, Radix Angelicae Sinensis 5g, Rhizoma Alismatis 25g, Rhizoma Curcumae 12g, Radix Astragali 5g, Pericarpium Citri Reticulatae Viride 20g, Rhizoma Imperatae 10g, Pericarpium Citri Reticulatae 15g, Radix Sophorae Flavescentis 5g, Radix Bupleuri 20g, Polyporus 12g, Radix Gentianae 15g, Herba Hedyotidis Diffusae 10g, Herba Lobeliae Chinensis 20g, Radix Glycyrrhizae 5g.
embodiment 5
Treat a Chinese medicine composition for hepatitis A, its raw material of Chinese medicine and weight proportion are: Fructus Mume 30g, Rhizoma Coptidis 10g, Cortex Phellodendri 15g, Herba Lysimachiae 5g, Radix Aconiti Lateralis Preparata 20g, Rhizoma Zingiberis 10g, Ramulus Cinnamomi 15g, Herba Asari 2g, Radix Ginseng 25g, Radix Angelicae Sinensis 10g, Rhizoma Alismatis 40g, Rhizoma Curcumae 5g, Radix Astragali 20g, Pericarpium Citri Reticulatae Viride 12g, Rhizoma Imperatae 25g, Pericarpium Citri Reticulatae 5g, Radix Sophorae Flavescentis 20g, Radix Bupleuri 10g, Polyporus 15g, Radix Gentianae 5g, Herba Hedyotidis Diffusae 20g, Herba Lobeliae Chinensis 10g, Radix Glycyrrhizae 15g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament.Concrete grammar is as follows: the raw material of Chinese medicine of prescription is put into container, adds cold water and covers powder, soaks 15 ~ 20 minutes, then adds water and do not have powder about 6 centimetres, carries out first time to decoct, and adopts intense fire to decoct, with slow fire boiling 20 ~ 30 minutes after boiling at a simmer; Second time decocts, and adds water and does not have powder about 4 centimetres, decocts 15 ~ 20 minutes after water boils.Decoct extracting juice twice, merge.
The present invention, with a kind of Chinese medicine composition for the treatment of hepatitis A given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: this Chinese medicine composition is applied to clinical observation case 100 example, man 54 example, female 46 example, 5 ~ 20 years old age.
Two, clinical manifestation:
1, heating, weak and poor appetite, Nausea and vomiting or the symptom of digestive tract such as abdominal distention, constipation; Liver enlargement, with touching a tender spot or kowtowing pain;
2, sclera, xanthochromia get rid of jaundice person caused by other diseases is had.
Three, usage and dosage: during clinical practice, potion on the one, decocting twice extracting juice is about 400ml, point morning, late twice empty stomach decoction being taken warmly.It within ten days, is a course for the treatment of.Treatments period is avoided cold and uncooked food the thing of pungent stimulation.
Four, criterion of therapeutical effect:
1, cure: clinical symptoms and sign disappear completely, and liver function recovery is normal;
2, effective: clinical symptoms and sign major part disappears or symptom significantly alleviates, liver function not yet recovers normal;
3, invalid: clinical symptoms and sign are without significant change.
Five, therapeutic effect: in this clinical observation case, takes medicine 2-5 the course for the treatment of, and recovery from illness 71 example, follows up a case by regular visits to and have no recurrence; Effective 22 examples, invalid 7 examples.There is not toxic and side effects in treatments period.
Six, model case:
Case 1: often certain, man, 9 years old.To occur the diseases such as weak, nauseating before ten days, but do not pay attention to, two days later, exacerbation of symptoms, fear of cold, urine is deep yellow, defecates greyish white, checks under the accompanying of layman to hospital, is diagnosed as hepatitis A.Hospitalization 1 week, poor effect.Take 2 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, weak, feel sick be eased; Continue to take 2 courses for the treatment of, all symptoms disappear completely, recovery from illness.Follow up a case by regular visits to after half a year without recurrence.
Case 2: Tan, female, 18 years old.The symptom of digestive tract such as recent appearance heating, weak and poor appetite, Nausea and vomiting, constipation.Check and find liver enlargement, and with tenderness, sclera, xanthochromia.Be diagnosed as hepatitis A.Take 3 courses for the treatment of of medicament prepared by Chinese medicine composition of the present invention, heating, the transference cure such as weak; Sclera, xanthochromia obviously alleviate; Continue to take 2 courses for the treatment of, recovery from illness.Follow up a case by regular visits to after 1 year without recurrence.
Claims (2)
1. treat the Chinese medicine composition of hepatitis A for one kind, it is characterized in that: its raw material of Chinese medicine and weight are: Fructus Mume 10-30 part, Rhizoma Coptidis 5-25 part, Cortex Phellodendri 5-20 part, Herba Lysimachiae 5-25 part, Radix Aconiti Lateralis Preparata 5-20 part, Rhizoma Zingiberis 5-25 part, Ramulus Cinnamomi 5-20 part, Herba Asari 2-8 part, Radix Ginseng 5-25 part, Radix Angelicae Sinensis 5-25 part, Rhizoma Alismatis 10-40 part, Rhizoma Curcumae 5-20 part, Radix Astragali 5-25 part, Pericarpium Citri Reticulatae Viride 5-20 part, Rhizoma Imperatae 5-25 part, Pericarpium Citri Reticulatae 5-20 part, Radix Sophorae Flavescentis 5-25 part, Radix Bupleuri 5-25 part, Polyporus 5-20 part, Radix Gentianae 5-20 part, Herba Hedyotidis Diffusae 5-25 part, Herba Lobeliae Chinensis 5-25 part, Radix Glycyrrhizae 5-15 part.
2. a kind of Chinese medicine composition for the treatment of hepatitis A according to claim 1, is characterized in that: its raw material of Chinese medicine and weight are: Fructus Mume 20 parts, Rhizoma Coptidis 15 parts, Cortex Phellodendri 10 parts, Herba Lysimachiae 15 parts, Radix Aconiti Lateralis Preparata 10 parts, Rhizoma Zingiberis 15 parts, Ramulus Cinnamomi 12 parts, Herba Asari 5 parts, Radix Ginseng 15 parts, Radix Angelicae Sinensis 15 parts, Rhizoma Alismatis 30 parts, Rhizoma Curcumae 10 parts, the Radix Astragali 15 parts, 10 parts, Pericarpium Citri Reticulatae Viride, Rhizoma Imperatae 15 parts, Pericarpium Citri Reticulatae 10 parts, Radix Sophorae Flavescentis 15 parts, Radix Bupleuri 15 parts, Polyporus 10 parts, Radix Gentianae 10 parts, Herba Hedyotidis Diffusae 15 parts, Herba Lobeliae Chinensis 15 parts, 10 parts, Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510619411.3A CN105106909A (en) | 2015-09-25 | 2015-09-25 | Traditional Chinese medicine composition for treating hepatitis A |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510619411.3A CN105106909A (en) | 2015-09-25 | 2015-09-25 | Traditional Chinese medicine composition for treating hepatitis A |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105106909A true CN105106909A (en) | 2015-12-02 |
Family
ID=54655178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510619411.3A Pending CN105106909A (en) | 2015-09-25 | 2015-09-25 | Traditional Chinese medicine composition for treating hepatitis A |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105106909A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107468923A (en) * | 2017-08-04 | 2017-12-15 | 张丽丽 | A kind of Chinese medicine for being used to treat hepatitis A |
| CN107929592A (en) * | 2017-12-14 | 2018-04-20 | 吴泽成 | A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1329913A (en) * | 2001-06-26 | 2002-01-09 | 张青梅 | Live-nourishing 'yanggan' pill |
| CN1562160A (en) * | 2004-04-21 | 2005-01-12 | 金海清 | Composite medicine for treating hepatitis B complication |
| CN103285295A (en) * | 2013-06-14 | 2013-09-11 | 王保德 | Traditional Chinese medicine preparation |
| CN104623362A (en) * | 2015-01-15 | 2015-05-20 | 汤华淑 | Traditional Chinese medicine composition for treating depression |
-
2015
- 2015-09-25 CN CN201510619411.3A patent/CN105106909A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1329913A (en) * | 2001-06-26 | 2002-01-09 | 张青梅 | Live-nourishing 'yanggan' pill |
| CN1562160A (en) * | 2004-04-21 | 2005-01-12 | 金海清 | Composite medicine for treating hepatitis B complication |
| CN103285295A (en) * | 2013-06-14 | 2013-09-11 | 王保德 | Traditional Chinese medicine preparation |
| CN104623362A (en) * | 2015-01-15 | 2015-05-20 | 汤华淑 | Traditional Chinese medicine composition for treating depression |
Non-Patent Citations (2)
| Title |
|---|
| 史昌河等: "《传染病新治》", 30 April 2015, 中医古籍出版社 * |
| 李石兰: "中草药防治病毒性肝炎的研究近况", 《陕西中医学院学报》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107468923A (en) * | 2017-08-04 | 2017-12-15 | 张丽丽 | A kind of Chinese medicine for being used to treat hepatitis A |
| CN107929592A (en) * | 2017-12-14 | 2018-04-20 | 吴泽成 | A kind of Chinese medicine composition for treating hepatitis A and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316295B (en) | Traditional Chinese composition for treating rheumatic arthritis | |
| CN103784887A (en) | Traditional Chinese medicinal composition for treating kidney deficiency lumbago | |
| CN103463561A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis sequelae | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN103536777B (en) | Traditional Chinese medicinal composition for treating knee osteoarthritis | |
| CN104043050A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN102949619B (en) | Traditional Chinese medicine composition for treating colitis | |
| CN105106909A (en) | Traditional Chinese medicine composition for treating hepatitis A | |
| CN103041301B (en) | Traditional Chinese medicine composition for treating icterohepatitis | |
| CN105288116A (en) | Traditional Chinese medicine composition for treating schizophrenia | |
| CN104758720A (en) | Traditional Chinese medicine composition for treating impotence | |
| CN102512647B (en) | Chinese herbal composition for treating abdominal pain due to deficiency-cold | |
| CN103223139A (en) | Traditional Chinese medicinal composition for treating chronic ulcerative colitis | |
| CN105832996A (en) | Traditional Chinese medicine composition for treating hysteria | |
| CN104548037A (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN104784417A (en) | Traditional Chinese medicine composition for curing impotentia | |
| CN103800833A (en) | Traditional Chinese medicine composition for treating deficiency of liver-yin and kidney-yin | |
| CN104116934A (en) | Traditional Chinese medicine composition for treating lumbago caused by kidney deficiency | |
| CN103536856B (en) | A kind of Chinese medicine composition for the treatment of lower abdominal pain | |
| CN102416150B (en) | Chinese medicinal composition for treating diarrhoea | |
| CN105560737A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN104173930A (en) | Traditional Chinese medicine composition for treating cold-damp lumbago | |
| CN106075268A (en) | A kind of Chinese medicine composition treating scabies | |
| CN105477454A (en) | Traditional Chinese medicine composition for treating eczema | |
| CN105250956A (en) | Chinese herb composition for treating colitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151202 |
|
| WD01 | Invention patent application deemed withdrawn after publication |